GPT-Rosalind: OpenAI's 2026 Life Sciences AI Model
April 18, 2026
OpenAI's GPT-Rosalind is its first frontier model built for drug discovery, biology, and translational medicine. Benchmarks, partners, and access details.
#vertical-ai
OpenAI Acquires Hiro Finance: The Vertical AI Shift Begins
April 15, 2026
OpenAI acquires Hiro Finance (April 2026): the vertical AI shift begins. Why consumer personal-finance AI needs different infra from general-purpose chatbots.